We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
For the notification of diagnosis of cases not identified through screening, this form covers the 6 inherited metabolic diseases (IMDs).
Screening laboratories can use these template letters to contact clinicians about a presumed positive newborn screening result for inherited metabolic diseases.
Advice and guidance on the health needs of migrant patients from Ukraine for healthcare practitioners.
Advice and guidance on the health needs of migrant patients from Afghanistan for healthcare practitioners.
How the MHRA makes decisions on what is a medicinal product (borderline products).
Projects granted during 2014 that have a primary purpose of translational and applied research: human endocrine or metabolism disorders.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.